Prenetics Global (NasdaqGM:PRE) Conference January 21, 2026 08:30 AM ET Company ParticipantsDanny Yeung - CEOConference Call ParticipantsAlex Hantman - Equity Research AnalystAlex HantmanWelcome, everyone, to this session of our January 2026 MicroCap conference. I'm Alex Hantman, and I serve as an equity research analyst here at Sidoti & Company. Today, we're pleased to be in conversation with Danny Yeung, the CEO and co-founder of Prenetics, ticker PRE. During the presentation, please feel welcome to submi ...

Robert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Airdrie, Alberta, Canada, Robert has earned Bachelor of Arts and Master of Business Administration (MBA) degrees.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the com ...

Clear Street recorded a 160% revenue jump in the first nine months of 2025, the Wall Street firm revealed on Tuesday in its U.S. initial public offering paperwork, as a busy year for new listings take... ...

Core Viewpoint - Prenetics Global Limited has decided to pause its Bitcoin purchases and redirect its capital towards the production and sale of its premium supplement, IM8 [1] Company Strategy - The company is reallocating resources from cryptocurrency investments to focus on its health supplement product line, indicating a strategic shift in its business model [1] Financial Implications - The decision to pause Bitcoin purchases suggests a potential reassessment of the company's investment strategy, which may impact its financial performance and capital allocation in the near term [1]

Core Insights - Prenetics has completed the sale of its 3PL distribution business, Europa Sports Partners, in an all-stock transaction valued at up to $13 million, contingent on performance milestones [1] - This divestiture allows Prenetics to focus on IM8, a rapidly growing supplement brand, aiming to enhance long-term shareholder value through global scaling [1] - The operating model of Europa became misaligned with Prenetics' long-term logistics and global expansion needs as IM8 continues to grow in various international markets [1]

Core Insights - Prenetics Global Limited has completed the sale of its 3PL distribution business, Europa Sports Partners, valued at up to $13 million, to focus on its IM8 brand [1][2][3] - The company maintains a strong balance sheet with over $70 million in cash and cash equivalents, 510 BTC, and zero debt, totaling approximately $118 million in liquidity [1][3] - The divestiture is part of Prenetics' strategic portfolio optimization, following the $72 million sale of ACT Genomics in October 2025, aimed at concentrating resources on the high-growth IM8 business [3][5] Financial Performance - The sale of the Europa business, completed on January 1, 2026, will not impact the company's revenue for fiscal year 2025, which will include the full-year contribution from Europa [4] - Prenetics projects total revenues from IM8 to be between $180 million and $200 million for the full year 2026 [3] - The divestiture is expected to improve operating margins starting Q2 2026, as the company will no longer incur approximately $6 million in operating losses from the Europa business [6] Strategic Focus - The sale allows Prenetics to sharpen its focus on IM8, which is rapidly scaling across international markets, aligning with the company's long-term logistics and global expansion requirements [2][5] - Prenetics plans to continue reviewing its remaining non-core assets, including a 35% stake in Insighta, valued at $70 million, to further simplify its business structure [7] - The company is optimistic about the future opportunities for IM8, which has achieved over $100 million in annual recurring revenue within 11 months of launch [8]

Core Viewpoint - Prenetics Global Ltd. has decided to abandon its Bitcoin treasury strategy to focus on its supplement brand IM8, which has shown rapid growth and reached $100 million in annualized recurring revenue within 11 months [1][2]. Group 1: Company Strategy - The CEO of Prenetics, Danny Yeung, stated that the success of IM8 has exceeded expectations, leading the management team to unanimously agree on focusing efforts on this opportunity to create sustainable shareholder value [2]. - Prenetics initially launched its Bitcoin treasury strategy in June, planning to purchase $20 million worth of Bitcoin and appointing Andy Cheung to its board [2][3]. - The company had aimed to reach $1 billion in annualized revenue and $1 billion in Bitcoin holdings, having raised $48 million from investors, including Kraken and Exodus, to support this strategy [4]. Group 2: Financial Performance - As of December 30, Prenetics reported holding $70 million in cash and 510 BTC valued at nearly $46 million [4]. - The decision to abandon the Bitcoin strategy comes amid a prolonged downturn in the cryptocurrency market, with Bitcoin prices dropping significantly from a record high of $126,000 to a low of $80,600 [5].

CHARLOTTE, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced an update to its previously announced voluntary warrant exchange program. Updated Participation and Impact In connection with the Company’s prior financing round in October 2025, 2,722,642 Class A ordinary shares were issued, with one Class A warrant and one Class B warrant issued ...

Core Viewpoint - Prenetics Global Limited (PRE) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook driven by rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to significant stock transactions that affect price movements [4]. Company Performance and Investor Sentiment - The upgrade for Prenetics Global reflects an improvement in the company's underlying business, suggesting that investor sentiment may lead to increased stock prices [5][10]. - Over the past three months, the Zacks Consensus Estimate for Prenetics Global has risen by 13.3%, indicating a positive trend in earnings expectations [8]. Zacks Rating System Overview - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - Prenetics Global's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].

Core Insights - Prenetics Global has ceased accumulating Bitcoin as of December 4, focusing instead on its nutrition supplement brand IM8, which has shown significant revenue growth [1][4] - The company's existing Bitcoin holdings amount to 510 BTC, valued at approximately $45 million, which will be retained as a treasury reserve asset [1][4] - Prenetics' strategic pivot is aimed at maximizing long-term shareholder value through the IM8 brand, which has already achieved $100 million in recurring revenue within its first 11 months [4] Company Strategy - Prenetics initiated a "1 BTC per day" strategy on August 1, accumulating around 275 BTC worth about $31 million by October 27, but has now shifted focus away from Bitcoin accumulation [3] - The company raised $48 million in an oversubscribed equity round in October to support its Bitcoin strategy, with a long-term goal of reaching $1 billion in Bitcoin holdings within five years [3] - The decision to stop Bitcoin purchases reflects a disciplined approach to strategic decision-making, emphasizing the commitment to sustainable shareholder value [2] Financial Performance - Following the announcement of the strategic shift, Prenetics' stock (PRE) fell by 3.5%, trading around $15.74, although it has risen 189% year-to-date [6] - In contrast, Bitcoin has experienced a decline of approximately 5.6% during the same period, indicating a challenging market environment for digital assets [6] - Other companies in the digital asset treasury space, such as ETHZilla, have also shifted focus away from crypto holdings, highlighting a broader trend in the industry [5]